Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-09-15 Purchase | 2025-09-16 06:15 am | Aardvark Therapeutics Inc. | AARD | Lee Tien-Li Chief Executive Officer 10% Owner | 10,000 | $9.6624 | $96,624 | 3,017,412 (Indirect Direct) | View |
| 2025-09-10 Purchase | 2025-09-12 8:28 pm | Aardvark Therapeutics Inc. | AARD | Lee Tien-Li Chief Executive Officer 10% Owner | 20,000 | $8.0327 | $160,654 | 3,007,412 (Indirect Direct) | View |
| 2025-09-09 Purchase | 2025-09-10 5:36 pm | Aardvark Therapeutics Inc. | AARD | Sun Nelson Chief Financial Officer | 6,000 | $8.0733 | $48,440 | 105,484 (Direct) | View |
| 2025-02-14 Purchase | 2025-02-19 5:44 pm | Aardvark Therapeutics Inc. | AARD | Decheng Capital Global Life Sciences Fund IV L.P. Decheng Capital Management IV (Cayman) LLC Decheng Capital Global Healthcare Fund (Master) LP Decheng Capital Global Healthcare GP LLC Cui Xiangmin 10% Owner | 1,250,000 | $16 | $20,000,000 | 958,412 (Indirect) | View |
| 2025-02-14 Purchase | 2025-02-19 4:35 pm | Aardvark Therapeutics Inc. | AARD | Lee Tien-Li Chief Executive Officer 10% Owner | 16,542 | $16 | $264,672 | 2,970,203 (Indirect Direct) | View |
| 2025-02-14 Purchase | 2025-02-19 4:30 pm | Aardvark Therapeutics Inc. | AARD | Sun Nelson Chief Financial Officer | 10,000 | $16 | $160,000 | 99,484 (Direct) | View |
| 2025-02-14 Purchase | 2025-02-19 4:02 pm | Aardvark Therapeutics Inc. | AARD | Cormorant Asset Management LP Chen Bihua Former 10% Owner | 187,500 | $16 | $3,000,000 | 987,689 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-08-28 Exercise | 2025-08-29 4:05 pm | N/A 2034-07-20 | Aardvark Therapeutics Inc. | AARD | Lee Tien-Li Chief Executive Officer 10% Owner | 17,209 | $0 | 3,029,207 (Direct) | View |
| 2025-08-28 Exercise | 2025-08-29 4:05 pm | N/A N/A | Aardvark Therapeutics Inc. | AARD | Lee Tien-Li Chief Executive Officer 10% Owner | 17,209 | $4.24 | 3,029,207 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:05 pm | N/A 2035-06-11 | Aardvark Therapeutics Inc. | AARD | Lee Tien-Li Chief Executive Officer 10% Owner | 549,534 | $0 | 549,534 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:05 pm | N/A 2035-06-11 | Aardvark Therapeutics Inc. | AARD | Chi Jeffrey Director | 61,017 | $0 | 61,017 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:05 pm | N/A 2035-06-11 | Aardvark Therapeutics Inc. | AARD | Jaiman Manasi Chief Medical Officer | 126,999 | $0 | 126,999 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:05 pm | N/A 2035-06-11 | Aardvark Therapeutics Inc. | AARD | Baynes Roy D. Director | 30,508 | $0 | 30,508 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:05 pm | N/A 2035-06-11 | Aardvark Therapeutics Inc. | AARD | Tong Victor Edward Jr Director | 61,017 | $0 | 61,017 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:05 pm | N/A 2035-06-11 | Aardvark Therapeutics Inc. | AARD | Sun Nelson Chief Financial Officer | 209,826 | $0 | 209,826 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:05 pm | N/A 2035-06-11 | Aardvark Therapeutics Inc. | AARD | Jones Bryan Chief Operating Officer | 122,033 | $0 | 122,033 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:05 pm | N/A 2035-06-11 | Aardvark Therapeutics Inc. | AARD | Graf Susan E Director | 30,508 | $0 | 30,508 (Direct) | View |
| 2025-02-14 Conversion | 2025-02-19 5:44 pm | N/A N/A | Aardvark Therapeutics Inc. | AARD | Decheng Capital Global Life Sciences Fund IV L.P. Decheng Capital Management IV (Cayman) LLC Decheng Capital Global Healthcare Fund (Master) LP Decheng Capital Global Healthcare GP LLC Cui Xiangmin 10% Owner | 25,269,999 | $0 | 958,412 (Indirect) | View |
| 2025-02-14 Conversion | 2025-02-19 4:57 pm | N/A N/A | Aardvark Therapeutics Inc. | AARD | Chi Jeffrey Director | 1,263,499 | $0 | 133,364 (Indirect) | View |
| 2025-02-14 Conversion | 2025-02-19 4:48 pm | N/A N/A | Aardvark Therapeutics Inc. | AARD | Vickers Venture Fund VI Pte Ltd 10% Owner | 19,430,250 | $0 | 2,050,902 (Indirect) | View |
| 2025-02-14 Conversion | 2025-02-19 4:35 pm | N/A N/A | Aardvark Therapeutics Inc. | AARD | Lee Tien-Li Chief Executive Officer 10% Owner | 391,305 | $0 | 2,970,203 (Direct) | View |
| 2025-02-14 Conversion | 2025-02-19 4:30 pm | N/A N/A | Aardvark Therapeutics Inc. | AARD | Sun Nelson Chief Financial Officer | 66,333 | $0 | 99,484 (Direct) | View |
| 2025-02-14 Conversion | 2025-02-19 4:02 pm | N/A N/A | Aardvark Therapeutics Inc. | AARD | Cormorant Asset Management LP Chen Bihua Former 10% Owner | 7,580,999 | $0 | 987,689 (Indirect) | View |
Ownership | 2025-02-12 7:47 pm | N/A N/A | Aardvark Therapeutics Inc. | AARD | Decheng Capital Global Life Sciences Fund IV L.P. Decheng Capital Management IV (Cayman) LLC Decheng Capital Global Healthcare Fund (Master) LP Decheng Capital Global Healthcare GP LLC Cui Xiangmin 10% Owner | 0 | $0 | 2,667,299 (Indirect) | View |
Ownership | 2025-02-12 7:24 pm | N/A 2030-12-08 | Aardvark Therapeutics Inc. | AARD | Jones Bryan Chief Operating Officer | 0 | $0 | 118,006 (Direct) | View |
Ownership | 2025-02-12 7:24 pm | N/A N/A | Aardvark Therapeutics Inc. | AARD | Sun Nelson Chief Financial Officer | 0 | $0 | 113,203 (Direct) | View |
Ownership | 2025-02-12 7:19 pm | N/A 2034-12-17 | Aardvark Therapeutics Inc. | AARD | Baynes Roy D. Director | 0 | $0 | 29,502 (Direct) | View |
Ownership | 2025-02-12 7:17 pm | N/A 2034-11-13 | Aardvark Therapeutics Inc. | AARD | Graf Susan E Director | 0 | $0 | 29,502 (Direct) | View |
Ownership | 2025-02-12 7:11 pm | N/A N/A | Aardvark Therapeutics Inc. | AARD | Vickers Venture Fund VI Pte Ltd 10% Owner | 0 | $0 | 2,050,902 (Indirect) | View |
Ownership | 2025-02-12 7:07 pm | N/A 2034-08-31 | Aardvark Therapeutics Inc. | AARD | Jaiman Manasi Chief Medical Officer | 0 | $0 | 177,012 (Direct) | View |
Ownership | 2025-02-12 6:55 pm | N/A N/A | Aardvark Therapeutics Inc. | AARD | Chi Jeffrey Director | 0 | $0 | 133,364 (Indirect) | View |
Ownership | 2025-02-12 6:49 pm | N/A N/A | Aardvark Therapeutics Inc. | AARD | Lee Tien-Li Chief Executive Officer 10% Owner | 0 | $0 | 3,012,665 (Direct) | View |
Ownership | 2025-02-12 5:18 pm | N/A N/A | Aardvark Therapeutics Inc. | AARD | Cormorant Asset Management LP Chen Bihua 10% Owner | 0 | $0 | 6,780,810 (Indirect) | View |